XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Millions
Total
Cumulative change related to the adoption of ASU 2023-02
Cumulative effect, period of adoption, adjusted balance
Common Stock Including Additional Paid in Capital [Member]
Common Stock Including Additional Paid in Capital [Member]
Cumulative change related to the adoption of ASU 2023-02
Common Stock Including Additional Paid in Capital [Member]
Cumulative effect, period of adoption, adjusted balance
Retained earnings
Retained earnings
Cumulative change related to the adoption of ASU 2023-02
Retained earnings
Cumulative effect, period of adoption, adjusted balance
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Cumulative change related to the adoption of ASU 2023-02
Accumulated other comprehensive loss
Cumulative effect, period of adoption, adjusted balance
Equity, beginning balance at Dec. 31, 2023 $ 3,227.5 $ 1.2 $ 3,228.7 $ 2,448.9 $ 0.0 $ 2,448.9 $ 1,135.1 $ 1.2 $ 1,136.3 $ (356.5) $ 0.0 $ (356.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 58.4     0.0     58.4     0.0    
Other comprehensive income (loss), net of tax expense $ (30.4)     0.0     0.0     (30.4)    
Stock repurchased and retired (in shares) 43,690                      
Non-vested common shares issued (in shares) 685,363                      
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 11,676                      
Common stock transactions:                        
Common shares purchased and retired $ (1.1)     (1.1)     0.0     0.0    
Non-vested common shares issued 0.0     0.0     0.0     0.0    
Non-vested common shares forfeited or canceled 0.0     0.0     0.0     0.0    
Stock-based compensation expense $ 2.9     2.9     0.0     0.0    
Common dividends (in dollars per share) $ 0.47                      
Common cash dividend declared $ (48.8)     0.0     (48.8)     0.0    
Equity, ending balance at Mar. 31, 2024 3,209.7     2,450.7     1,145.9     (386.9)    
Equity, beginning balance at Dec. 31, 2024 3,304.0     2,459.5     1,166.4     (321.9)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 50.2     0.0     50.2     0.0    
Other comprehensive income (loss), net of tax expense $ 54.4     0.0     0.0     54.4    
Stock repurchased and retired (in shares) 106,630                      
Non-vested common shares issued (in shares) 480,289                      
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited 49,862                      
Common stock transactions:                        
Common shares purchased and retired $ (3.2)     (3.2)     0.0     0.0    
Non-vested common shares issued 0.0     0.0     0.0     0.0    
Non-vested common shares forfeited or canceled 0.0     0.0     0.0     0.0    
Stock-based compensation expense $ 3.9     3.9     0.0     0.0    
Common dividends (in dollars per share) $ 0.47                      
Common cash dividend declared $ (48.0)     0.0     (48.0)     0.0    
Equity, ending balance at Mar. 31, 2025 $ 3,361.3     $ 2,460.2     $ 1,168.6     $ (267.5)